FDA issues guidance on clinical trial rules compliance

08/29/2013 | PharmaTimes (U.K.) · Clinica (subscription required)

Guidance aimed at making sure that drug and medical device trials present limited risk to patients and satisfy regulations has been released by the FDA. The guidance outlines how institutional review boards should assess qualifications of researchers and the fitness of trial sites.

View Full Article in:

PharmaTimes (U.K.) · Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX